
Bioethics Flashpoints of the Next Decade
The Lancet Voice podcast explores the bioethical challenges that will dominate medicine over the next decade, featuring bioethicist Professor Ezekiel Emanuel. Emanuel recounts how a dual background in chemistry and philosophy steered him toward oncology, where everyday clinical dilemmas forced him to confront questions of consent, end‑of‑life care, and the staggering costs of treatment. Central to his work is a four‑principle framework for allocating scarce medical resources: maximize benefits, ensure equal moral concern, prioritize the disadvantaged, and reward social contribution. By translating each principle into concrete rules—such as saving the most lives or life‑years, using lotteries or age‑based priority—Emanuel demonstrated that no single value suffices; a pluralistic approach is required. The “whale graph” illustrates society’s strongest preference for allocating resources to young adults, reflecting both potential and investment. Emanuel’s framework proved prescriptive during the COVID‑19 pandemic, guiding vaccine distribution that favored high‑risk older adults for maximal benefit and frontline healthcare workers for social contribution. He also cites earlier policy debates, like the 2005 HHS pandemic plan that mistakenly prioritized the elderly, and how historical data from the 1918 flu pandemic reshaped his stance toward youth priority. The conversation extends to global inequities, noting that emerging high‑cost therapies—GLP‑1 agonists, potential Alzheimer’s drugs, and HIV treatments—will test allocation principles worldwide. Looking ahead, the tension between cost‑effectiveness metrics (e.g., quality‑adjusted life years) and total budget impact will intensify as novel, expensive interventions become commonplace. Policymakers, clinicians, and industry must adopt robust ethical frameworks to balance individual needs with societal fairness, ensuring that scarce resources are deployed in ways that reflect both health outcomes and equity.

What Is in a Name Change? Moving From the Term PCOS to PMOS
The Lancet Pulse episode discusses the landmark decision to rename polycystic ovarian syndrome (PCOS) as polyendocrine metabolic ovarian syndrome (PMOS). The change reflects a growing scientific consensus that the condition is fundamentally an endocrine and metabolic disorder, not a...

Is There a Link Between Diet and Mental Health?
The Lancet podcast explores whether a ketogenic diet can influence mental health, focusing on its emerging role in managing bipolar disorder. Host Niall Boyce and guest Daniel "Danny" Smith discuss the diet’s composition—high fat, low carbohydrate—and its historical use for...
[Comment] Life at the Water's Edge: A Lancet Commission on Sea-Level Rise, Health, and Justice
The Lancet Commission’s latest comment warns that accelerating sea‑level rise will reshape daily life for hundreds of millions, with up to 410 million people projected to live below the high‑tide line by 2100. It details how rising waters amplify disease transmission,...
[Correspondence] Suicidal Crisis: First Regulatory Approval of IV Racemic Ketamine
In March 2026 France became the first country to grant regulatory approval for intravenous racemic ketamine as a treatment for adult severe suicidal crisis. Clinical trials have shown that a single 0.5 mg/kg infusion over 40 minutes can blunt suicidal ideation...
[Correspondence] War Economies and Collapsing Health Systems
Rising defence budgets are crowding out public health financing, with a 1 % increase in military spending cutting health budgets by 0.62 % globally and 0.96 % in low‑income nations. Conflict‑related destruction, supply‑chain blockades and sanctions have already caused tens of millions of...
[Correspondence] Cancer, Climate Change, Fossil Fuels, and War: A Call for Action
Nancy Krieger’s correspondence highlights a growing body of research linking climate change to cancer, while exposing a glaring gap in accountability for fossil‑fuel‑driven wars. The article cites recent studies on pollution, occupational exposures, and climate refugees, and draws attention to...
[Correspondence] Sound Mind, Sound Place: Ibasho and Post-Disaster Mental Health
The correspondence argues that post‑disaster mental health must move beyond acute symptom checklists toward community‑based recovery, highlighting Japan’s *ibasho*—a locally‑led place that embeds individuals in social networks and meaningful roles. Data from the 2011 Great East Japan Earthquake show that...
[Comment] Targeted Advertising in Generative Artificial Intelligence Chatbots: A New Public Health Risk
OpenAI announced it will embed targeted advertising in the free and low‑cost versions of ChatGPT, pairing the rollout with safeguards such as ad‑response separation, privacy protections, age gating for users under 18, and limits on health‑related ads. The move addresses...
[Comment] Rethinking Country Classifications Towards a More Equitable Global Health Future
The authors argue that the World Bank’s income‑based country classification, which groups nations into low, middle and high income based on gross national income per capita, no longer reflects health system realities. They show that income alone masks profound heterogeneity...
[Articles] Deferral of Percutaneous Coronary Intervention in Patients Undergoing Transcatheter Aortic Valve Implantation (PRO-TAVI): An Investigator-Initiated, Multicentre, Open-Label, Non-Inferiority, Randomised...
The PRO‑TAVI investigator‑initiated trial randomised 466 patients with coronary artery disease undergoing transcatheter aortic valve implantation to either deferred percutaneous coronary intervention (PCI) or PCI before TAVI. At one year, the composite of all‑cause mortality, myocardial infarction, stroke and major...
[Comment] Coronary Revascularisation Before TAVI
Coronary artery disease affects up to half of patients referred for transcatheter aortic valve implantation (TAVI), raising the question of whether routine percutaneous coronary intervention (PCI) before valve replacement improves outcomes. The PRO‑TAVI trial, a multicenter non‑inferiority randomized study, compared...
[Articles] Aspirin versus Clopidogrel for Chronic Maintenance Monotherapy After Percutaneous Coronary Intervention: 10-Year Follow-Up of the HOST-EXAM Trial
Ten‑year extended follow‑up of the HOST‑EXAM trial compared clopidogrel 75 mg daily with aspirin 100 mg daily as chronic monotherapy after PCI. Among 5,438 patients, clopidogrel achieved a 25.4% incidence of the composite of death, MI, stroke, ACS readmission, or major bleeding...
[Comment] Moving Beyond Aspirin After Percutaneous Coronary Intervention: 10-Year Results From the HOST-EXAM Trial
The HOST-EXAM trial, with ten-year follow‑up, compared clopidogrel monotherapy to aspirin after percutaneous coronary intervention. Results showed clopidogrel achieved lower rates of major adverse cardiovascular events and major bleeding. The study enrolled over 5,000 patients from diverse centers, reinforcing the...
[Therapeutics] Pyruvate Kinase Activators in Hereditary Haemolytic Anaemias: Current Evidence and Clinical Potential
Hereditary hemolytic anemias affect millions worldwide and have few disease‑modifying options. Oral pyruvate kinase activators, especially mitapivat, increase glycolytic ATP production, correcting a common metabolic defect in red cells. Clinical trials have shown efficacy in pyruvate kinase deficiency, sickle cell...